GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » Total Assets

Rhythm Biosciences (ASX:RHY) Total Assets : A$5.93 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Rhythm Biosciences Total Assets?

Rhythm Biosciences's Total Assets for the quarter that ended in Dec. 2024 was A$5.93 Mil.

During the past 12 months, Rhythm Biosciences's average Total Assets Growth Rate was 116.90% per year. During the past 3 years, the average Total Assets Growth Rate was -1.40% per year. During the past 5 years, the average Total Assets Growth Rate was 3.70% per year.

During the past 7 years, Rhythm Biosciences's highest 3-Year average Total Assets Growth Rate was 63.80%. The lowest was -16.70%. And the median was 3.55%.

Total Assets is connected with ROA %. Rhythm Biosciences's annualized ROA % for the quarter that ended in Dec. 2024 was 31.62%. Total Assets is also linked to Revenue through Asset Turnover. Rhythm Biosciences's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

Rhythm Biosciences Total Assets Historical Data

The historical data trend for Rhythm Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Total Assets Chart

Rhythm Biosciences Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Total Assets
Get a 7-Day Free Trial 2.65 3.07 8.44 7.70 1.52

Rhythm Biosciences Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.04 7.70 1.94 1.52 5.93

Rhythm Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Rhythm Biosciences's Total Assets for the fiscal year that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (A: Jun. 2024 )+Total Liabilities (A: Jun. 2024 )
=0.867+0.652
=1.52

Rhythm Biosciences's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (Q: Dec. 2024 )+Total Liabilities (Q: Dec. 2024 )
=4.878+1.054
=5.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhythm Biosciences  (ASX:RHY) Total Assets Explanation

Total Assets is connected with ROA %.

Rhythm Biosciences's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %=Net Income (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=1.178/( (1.519+5.932)/ 2 )
=1.178/3.7255
=31.62 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Rhythm Biosciences's Asset Turnover for the quarter that ended in Dec. 2024 is

Asset Turnover
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (1.519+5.932)/ 2 )
=0/3.7255
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Rhythm Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » Total Assets
Comparable Companies
ASX:CTE ASX:BDX ASX:IIQ ASX:IBX ASX:GSS ASX:MAP TMO DHR XSWX:LONN A IDXX IQV SHSE:603259 MTD WAT NTRA LH DGX ICLR ILMN
Traded in Other Exchanges
N/A
Address
30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010
Website
https://www.rhythmbio.com
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.

Rhythm Biosciences Headlines

No Headlines